The Fed is Set to Cut Rates in September, Tariffs Have Limited Impact on CPI
According to ChainCatcher, citing Jinshi News, Guy Lebas, Chief Fixed Income Strategist at Janney Montgomery Scott, stated that July’s CPI was largely in line with expectations, and tariffs have had a limited impact on consumer prices, which provides grounds for the Federal Reserve to consider a rate cut in September. Although there is still some time before the meeting, the current inflation data is not a cause for concern. Lebas noted that the effects of tariffs have not yet fully materialized, and future inflation may rise, or companies may be absorbing the impact of tariffs, thus preventing it from being passed on to consumer inflation.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Starbucks (SBUX.US) officially refutes rumors: clearly denies acquiring Chipotle (CMG.US), focuses on "Back to Starbucks" transformation strategy
Starbucks publicly clarified on Monday that the company has not acquired Chipotle Mexican Grill, putting an end to the previous acquisition rumors.
BlackRock increases allocation to short-term US Treasuries and lowers US stocks: "Rate hike bets have gone too far," high yields should be prioritized
BlackRock has turned bullish on U.S. Treasury bonds for the first time in six years, upgrading short-term bonds to overweight and downgrading U.S. equities to neutral, stating that rate hike expectations are excessive and it is time to lock in yields.

AstraZeneca (AZN.US) Relizumab's new indication is expected to be included in priority review
Relizumab is a blockbuster product under AstraZeneca, with global sales projected to reach 4.718 billions USD in 2025 (YOY +20.23%).
4 Big Bank Earnings to Watch This Week as Wall Street Turns Bullish
